Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DMSO vs DMSO + Botox for Refractory Bladder Pain Syndrome
NCT03103594Phase 1Completed
- Sponsor
- University of Pennsylvania
- Start
- Aug 2015
- Primary completion
- Aug 2016
- Modality
- Recombinant Proteins and Enzymes
01
Overview
Phase 1, randomised trial of botulinum toxin type A in bladder pain syndrome (BPS) (2 arms), sponsored by University of Pennsylvania. Primary endpoint: Pain Score at 6 months. Started Aug 2015; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
bladder pain syndrome (BPS)
Beyond the preview
Go deeper on NCT03103594.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03103594.